Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

This analysis involving patients in the U.K. and Ireland provides reassurance on the effectiveness of two adalimumab biosimilars for the treatment of psoriasis ... since the biologic's patent ...

It's my honor and pleasure to welcome Dr Robert Kushner to Psoriasis ... is the importance of treatment adherence. And maybe it's not as important now with some of the biologics as it was before ...

Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following approval by the U.S. Food and Drug Administration (FDA) in December 2024.

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to ...

Learn about different types of eczema, symptoms, treatment options, and how to differentiate from other skin conditions.

Seeking treatment for depression ... and some experts believe biologic treatments for psoriasis may help prevent PsA from developing. While more work is needed to confirm this, ensuring everyone ...